SCHEMBL3396205

SCHEMBL3396205

Cc1ccc(-c2nc3cc(C)ccn3c2C(O)Nc2cc(C)ccn2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.44
MAPT P10636 6/20 0.43
SYK P43405 1/20 0.41
GAA P10253 7/20 0.40
SMN1; SMN2 Q16637 5/20 0.40
HTT P42858 2/20 0.40
KMT2A Q03164 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
POLB P06746 1/20 0.40
FDPS P14324 2/20 0.39
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 2/20 0.38
LMNA P02545 1/20 0.38
GFER P55789 1/20 0.38
TP53 P04637 1/20 0.38
CGAS Q8N884 1/20 0.38
PKM P14618 1/20 0.37
PKLR P30613 1/20 0.37
MITF O75030 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3433131 0.89 MDM2 (0.41) ALOX5MAPTSYKGAASMN1; SMN2
SCHEMBL15879650 0.82 SMN1; SMN2 (0.43) MAPTSYKGAASMN1; SMN2HTT
SCHEMBL3395698 0.81 PHGDH (0.38) MAPTSYKGAASMN1; SMN2HTT
SCHEMBL3388535 0.78 MAPK14 (0.35) ALOX5MAPTGAASMN1; SMN2POLB
SCHEMBL14632152 0.78 ALDH1A1 (0.46) MAPTGAASMN1; SMN2HTTKMT2A
SCHEMBL7086732 0.71 MAPT (0.46) ALOX5MAPTGAASMN1; SMN2HTT
SCHEMBL12056713 0.67 ALOX5 (0.54) ALOX5MAPTGAASMN1; SMN2HTT
SCHEMBL1691295 0.67 SMN1; SMN2 (0.51) ALOX5MAPTGAASMN1; SMN2POLB
SCHEMBL7235017 0.65 NPC1 (0.49) ALOX5MAPTGAASMN1; SMN2HTT
SCHEMBL3393907 0.65 TP53 (0.45) MAPTGAASMN1; SMN2POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150239905-A1 IMIDAZOPYRIDINE COMPOUNDS BIOVITRUM AB (PUBL) (SE) 2015-08-27 US disclosed
US-20140206662-A1 Imidazopyridine Compounds PROXIMAGEN LTD. (GB) 2014-07-24 US disclosed
EP-2376490-B1 IMIDAZOPYRIDINE COMPOUNDS PROXIMAGEN LTD (GB) 2013-01-23 EP disclosed
WO-2010064020-A1 IMIDAZOPYRIDINE COMPOUNDS PROXIMAGEN LTD. (GB) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239905-A1 IMIDAZOPYRIDINE COMPOUNDS SSB, MIF, IDO1 ALOX5 55/4885MAPT 3076/4885SYK 408/4885
US-20140206662-A1 Imidazopyridine Compounds SSB, NFKBIA, TPMT ALOX5 150/4885MAPT 2195/4885SYK 221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.